157 related articles for article (PubMed ID: 22480177)
1. The relationship between single nucleotide polymorphisms in 5-HT2A signal transduction-related genes and the response efficacy to selective serotonin reuptake inhibitor treatments in Chinese patients with major depressive disorder.
Li HF; Yu X; Yang K; He CY; Kou SJ; Cao SX; Xie GR
Genet Test Mol Biomarkers; 2012 Jul; 16(7):667-71. PubMed ID: 22480177
[TBL] [Abstract][Full Text] [Related]
2. Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
Masiran R; Sidi H; Mohamed Z; Mohd Nazree NE; Nik Jaafar NR; Midin M; Das S; Mohamed Saini S
J Sex Med; 2014 Apr; 11(4):1047-1055. PubMed ID: 24533444
[TBL] [Abstract][Full Text] [Related]
3. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.
Qesseveur G; Petit AC; Nguyen HT; Dahan L; Colle R; Rotenberg S; Seif I; Robert P; David D; Guilloux JP; Gardier AM; Verstuyft C; Becquemont L; Corruble E; Guiard BP
Neuropharmacology; 2016 Jun; 105():142-153. PubMed ID: 26764241
[TBL] [Abstract][Full Text] [Related]
4. HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.
Kishi T; Yoshimura R; Kitajima T; Okochi T; Okumura T; Tsunoka T; Yamanouchi Y; Kinoshita Y; Kawashima K; Naitoh H; Nakamura J; Ozaki N; Iwata N
Neuromolecular Med; 2010 Sep; 12(3):237-42. PubMed ID: 19937159
[TBL] [Abstract][Full Text] [Related]
5. Temperament profiles, 5-HT2A genotype, and response to treatment with SSRIs in major depression.
Andre K; Kampman O; Setälä-Soikkeli E; Viikki M; Poutanen O; Nuolivirta T; Mononen N; Lehtimäki T; Leinonen E; Illi A
J Neural Transm (Vienna); 2010 Dec; 117(12):1431-4. PubMed ID: 21136126
[TBL] [Abstract][Full Text] [Related]
6. Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD.
Viikki M; Huuhka K; Leinonen E; Illi A; Setälä-Soikkeli E; Huuhka M; Mononen N; Lehtimäki T; Kampman O
Neurosci Lett; 2011 Aug; 501(1):20-4. PubMed ID: 21741447
[TBL] [Abstract][Full Text] [Related]
7. Catecholamine pathway polymorphisms and antidepressant response.
Yin L; Zhang X; Huang Y; Sun X
Asia Pac Psychiatry; 2016 Jun; 8(2):109-17. PubMed ID: 25854875
[TBL] [Abstract][Full Text] [Related]
8. 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients.
Kato M; Zanardi R; Rossini D; De Ronchi D; Okugawa G; Kinoshita T; Colombo C; Serretti A
Psychiatry Res; 2009 May; 167(1-2):97-105. PubMed ID: 19361869
[TBL] [Abstract][Full Text] [Related]
9. Association between 5HT2A polymorphism and selective serotonin re-uptake inhibitor (SSRI)-induced sexual desire disorder (SDD) among Malaysian women.
Masiran R; Sidi H; Mohamed Z; Mohamed Saini S; Nik Jaafar NR
Asia Pac Psychiatry; 2013 Apr; 5 Suppl 1():41-9. PubMed ID: 23857836
[TBL] [Abstract][Full Text] [Related]
10. Association study of 5-HT1A, 5-HT2A polymorphisms with schizophrenia and major depressive disorder in the Han Chinese population.
Zhang R; Bi Y; Niu W; Huang X; Chen S; Li X; Wu X; Cao Y; Yang F; Wang L; Li W; Xu Y; He L; Yu T; He G
Neurosci Lett; 2016 Dec; 635():39-43. PubMed ID: 27756686
[TBL] [Abstract][Full Text] [Related]
11. Association study between 5-HT2A and NET gene polymorphisms and recurrent major depression disorder in Chinese Han population.
Cao S; Li H; Lou L; Xie Z; Zhao X; Pang J; Sui J; Xie G
Pak J Pharm Sci; 2015 May; 28(3 Suppl):1101-8. PubMed ID: 26051731
[TBL] [Abstract][Full Text] [Related]
12. Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients.
Oz MD; Baskak B; Uckun Z; Artun NY; Ozdemir H; Ozel TK; Ozguven HD; Suzen HS
Pharmacogenomics J; 2020 Jun; 20(3):443-450. PubMed ID: 31792367
[TBL] [Abstract][Full Text] [Related]
13. SLC17A7 gene may be the indicator of selective serotonin reuptake inhibitor treatment response in the Chinese Han population.
Li X; Yu T; Huang X; Cao Y; Li X; Liu B; Yang F; Li W; Zhao X; Feng G; Zhang X; Dong Z; Lin Y; Li X; He L; Sun X; He G
J Clin Psychopharmacol; 2014 Jun; 34(3):331-6. PubMed ID: 24743714
[TBL] [Abstract][Full Text] [Related]
14. 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.
Illi A; Setälä-Soikkeli E; Viikki M; Poutanen O; Huhtala H; Mononen N; Lehtimäki T; Leinonen E; Kampman O
Neuroreport; 2009 Aug; 20(12):1125-8. PubMed ID: 19590397
[TBL] [Abstract][Full Text] [Related]
15. Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder.
Perlis RH; Fijal B; Adams DH; Sutton VK; Trivedi MH; Houston JP
Biol Psychiatry; 2009 May; 65(9):785-91. PubMed ID: 19095219
[TBL] [Abstract][Full Text] [Related]
16. Klotho Gene and Selective Serotonin Reuptake Inhibitors: Response to Treatment in Late-Life Major Depressive Disorder.
Paroni G; Seripa D; Fontana A; D'Onofrio G; Gravina C; Urbano M; Addante F; Lozupone M; Copetti M; Pilotto A; Greco A; Panza F
Mol Neurobiol; 2017 Mar; 54(2):1340-1351. PubMed ID: 26843110
[TBL] [Abstract][Full Text] [Related]
17. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
[TBL] [Abstract][Full Text] [Related]
18. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
[TBL] [Abstract][Full Text] [Related]
19. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
Seripa D; Pilotto A; Paroni G; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Paris F; Panza F; Padovani A; Pilotto A
J Psychopharmacol; 2015 May; 29(5):623-33. PubMed ID: 25827644
[TBL] [Abstract][Full Text] [Related]
20. TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment Outcome in the Chinese Population with Major Depression.
Yin L; Zhang YY; Zhang X; Yu T; He G; Sun XL
Pharmacopsychiatry; 2015 May; 48(3):95-103. PubMed ID: 25642918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
